Many studies suggest that the status of the DDR pathway affects cancer cells’ response to chemotherapy, with loss of DDR elements increasing the sensitivity to DNA-damaging platinum and PARP inhibition, such as BRCA1, BRCA2, BARD1, ATM, and PALB227. The gene discussed is ATM; the disease is cancer.